D
Renalytix Plc
RNLXY
$0.225
$0.00853.93%
D
Sell
3/6/2025Upgraded
Renalytix Plc (RNLXY) was upgraded to D- from E+ on 3/6/2025 due to an increase in the growth index, total return index and volatility index. Operating cash flow increased 50.98% from -$7.83M to -$3.84M, EBIT increased 25.94% from -$5.53M to -$4.09M, and earnings per share increased from -$0.0512 to -$0.0447.
Renalytix Plc (RNLXY) was upgraded to D- from E+ on 3/6/2025 due to an increase in the growth index, total return index and volatility index. Operating cash flow increased 50.98% from -$7.83M to -$3.84M, EBIT increased 25.94% from -$5.53M to -$4.09M, and earnings per share increased from -$0.0512 to -$0.0447.
E
Sell
5/29/2024Downgrade
Renalytix Plc (RNLX) was downgraded to E+ from D- on 5/29/2024 due to a decline in the volatility index and total return index.
Renalytix Plc (RNLX) was downgraded to E+ from D- on 5/29/2024 due to a decline in the volatility index and total return index.
D
Sell
5/14/2024Upgraded
Renalytix Plc (RNLX) was upgraded to D- from E+ on 5/14/2024 due to an increase in the volatility index and valuation index.
Renalytix Plc (RNLX) was upgraded to D- from E+ on 5/14/2024 due to an increase in the volatility index and valuation index.
E
Sell
4/26/2024Downgrade
Renalytix Plc (RNLX) was downgraded to E+ from D- on 4/26/2024 due to a decline in the volatility index.
Renalytix Plc (RNLX) was downgraded to E+ from D- on 4/26/2024 due to a decline in the volatility index.
D
Sell
4/11/2024Upgraded
Renalytix Plc (RNLX) was upgraded to D- from E+ on 4/11/2024 due to a large increase in the growth index and valuation index. Total revenue increased 36.87% from $518 to $709, earnings per share increased from -$0.1185 to -$0.09, and EBIT increased 16.1% from -$9.93M to -$8.34M.
Renalytix Plc (RNLX) was upgraded to D- from E+ on 4/11/2024 due to a large increase in the growth index and valuation index. Total revenue increased 36.87% from $518 to $709, earnings per share increased from -$0.1185 to -$0.09, and EBIT increased 16.1% from -$9.93M to -$8.34M.
E
Sell
3/14/2023Downgrade
Renalytix Plc (RNLXY) was downgraded to E+ from D- on 03/14/2023.
Renalytix Plc (RNLXY) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/23/2023Upgraded
Renalytix Plc (RNLX) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
Renalytix Plc (RNLX) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
E
Sell
2/8/2023Downgrade
Renalytix Plc (RNLX) was downgraded to E+ from D- on 2/8/2023 due to a large decline in the solvency index and valuation index. Debt to equity increased from 0.4 to 0.58, and the quick ratio declined from 3.59 to 2.42.
Renalytix Plc (RNLX) was downgraded to E+ from D- on 2/8/2023 due to a large decline in the solvency index and valuation index. Debt to equity increased from 0.4 to 0.58, and the quick ratio declined from 3.59 to 2.42.
D
Sell
10/25/2022Upgraded
Renalytix Plc (RNLX) was upgraded to D- from E+ on 10/25/2022 due to an increase in the volatility index and valuation index.
Renalytix Plc (RNLX) was upgraded to D- from E+ on 10/25/2022 due to an increase in the volatility index and valuation index.
E
Sell
10/5/2022Downgrade
Renalytix Plc (RNLX) was downgraded to E+ from D- on 10/5/2022 due to a decline in the volatility index and total return index.
Renalytix Plc (RNLX) was downgraded to E+ from D- on 10/5/2022 due to a decline in the volatility index and total return index.
D
Sell
9/20/2022Upgraded
Renalytix Plc (RNLX) was upgraded to D- from E+ on 9/20/2022 due to an increase in the valuation index and volatility index.
Renalytix Plc (RNLX) was upgraded to D- from E+ on 9/20/2022 due to an increase in the valuation index and volatility index.
E
Sell
7/5/2022Downgrade
Renalytix Plc (RNLX) was downgraded to E+ from D- on 7/5/2022 due to a decline in the solvency index, volatility index and growth index. The quick ratio declined from 5.33 to 2.22, EBIT declined 5.18% from -$13.85M to -$14.57M, and total revenue declined 3.91% from $845 to $812.
Renalytix Plc (RNLX) was downgraded to E+ from D- on 7/5/2022 due to a decline in the solvency index, volatility index and growth index. The quick ratio declined from 5.33 to 2.22, EBIT declined 5.18% from -$13.85M to -$14.57M, and total revenue declined 3.91% from $845 to $812.
D
Sell
5/5/2022Upgraded
Renalytix Plc (RNLX) was upgraded to D- from E+ on 5/5/2022 due to an increase in the valuation index.
Renalytix Plc (RNLX) was upgraded to D- from E+ on 5/5/2022 due to an increase in the valuation index.
E
Sell
4/20/2022Downgrade
Renalytix Plc (RNLX) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
Renalytix Plc (RNLX) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
D
Sell
2/11/2022Downgrade
Renalytix Plc (RNLX) was downgraded to D- from D on 2/11/2022 due to a major decline in the total return index, solvency index and volatility index. The quick ratio declined from 9.31 to 7.56.
Renalytix Plc (RNLX) was downgraded to D- from D on 2/11/2022 due to a major decline in the total return index, solvency index and volatility index. The quick ratio declined from 9.31 to 7.56.
D
Sell
11/23/2021Upgraded
Renalytix Plc (RNLX) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
Renalytix Plc (RNLX) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
Renalytix Plc (RNLXY) was downgraded to D- from D on 11/08/2021.
Renalytix Plc (RNLXY) was downgraded to D- from D on 11/08/2021.
D
Sell
3/9/2021Upgraded
Renalytix AI PLC (RNLX) was upgraded to D from E on 3/9/2021 due to a large increase in the total return index, volatility index and solvency index.
Renalytix AI PLC (RNLX) was upgraded to D from E on 3/9/2021 due to a large increase in the total return index, volatility index and solvency index.
E
Sell
1/4/2021Upgraded
Renalytix AI PLC (RNLX) was upgraded to E from E- on 1/4/2021 due to an increase in the efficiency index, volatility index and total return index. Total capital increased 138.84% from $36.58M to $87.38M.
Renalytix AI PLC (RNLX) was upgraded to E from E- on 1/4/2021 due to an increase in the efficiency index, volatility index and total return index. Total capital increased 138.84% from $36.58M to $87.38M.
E
Sell
10/9/2020None
Renalytix Plc (RNLXY) was downgraded to E- from U on 10/09/2020.
Renalytix Plc (RNLXY) was downgraded to E- from U on 10/09/2020.
OTC PK
03/14/2025 2:48PM Eastern
Quotes delayed
